title: Is it safe to decrease hemodynamic parameters to achieve bloodless surgical field during transnasal endoscopic procedures? Our experience in fifteen patients.
authors: A
authors: A
authors: Sieskiewicz
authors: A
authors: A
authors: Lewczuk
authors: A
authors: A
authors: Drozdowski
authors: T
authors: T
authors: Lyson
authors: M
authors: M
authors: Rogowski
authors: Z
authors: Z
authors: Mariak
mesh_terms: D000328:Adult; D018681:Anesthetics, General / Q000008:administration & dosage*; D001794:Blood Pressure / Q000502:physiology; D057668:Bloodless Medical and Surgical Procedures; D015331:Cohort Studies; D005260:Female; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage*; D008875:Middle Aged; D020768:Middle Cerebral Artery / Q000503:physiopathology; D057605:Natural Orifice Endoscopic Surgery / Q000009:adverse effects / Q000379:methods*; D010254:Paranasal Sinus Diseases / Q000503:physiopathology / Q000601:surgery*; D010880:Piperidines / Q000008:administration & dosage*; D012039:Regional Blood Flow / Q000502:physiology; D000077208:Remifentanil; D000077149:Sevoflurane; D055815:Young Adult
chemical_list: D018681:Anesthetics, General; D008738:Methyl Ethers; D010880:Piperidines; D000077149:Sevoflurane; D000077208:Remifentanil